News from pharmaleads A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Jun 11, 2018, 10:30 ETPharmaleads Presents New Data Showing DENKIs, a New Class of Painkillers, to be Devoid of Abuse Potential and Opiate Side-Effects

Clinical and preclinical data demonstrating efficacy, safety and tolerability presented at the Annual International Conference on Opioids in Boston...


Jan 03, 2018, 03:00 ETPharmaleads to Present at Biotech Showcase 2018 in San Francisco

Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate and non-addictive products for the management of acute and chronic...


Nov 06, 2017, 02:00 ETPharmaleads CEO to Present at Bio-Europe 2017

Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate products for the management of acute and chronic severe pain,...


Jun 29, 2017, 02:00 ETPharmaleads Reports Positive Phase I SAD Data with its Dual ENKephalinase Inhibitor (DENKI) PL265 for the Treatment of Neuropathic Pain

Pharmaleads, an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, today announced...


May 12, 2017, 02:00 ETPharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI), at the ARVO 2017 Annual Meeting

Pharmacology research conducted in conjunction with The Vision Institute, Paris Pharmaleads, an emerging pharmaceutical company developing innovative ...


May 05, 2017, 03:00 ETPharmaleads to Present PL265 for Ocular Pain Results at the ARVO 2017 Annual Meeting in Baltimore

Pharmaleads, an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, today announced...